Back to search
FDAFDA · Food and drugs·Recall number Z-0631-2024

Covidien Valleylab FT10, FT Series Energy Platform, REF: VLFT10GEN, DLVLFT10GEN, VLFT10GENZD

Published January 10, 2024 · Recall initiated: November 16, 2023

Summary

FDA records medical device Class II recall Z-0631-2024, published January 10, 2024 and initiated November 16, 2023. Recalling firm: Covidien; Status: Ongoing; Reported quantity: 47,901 units; Lot: Ref-UDI: VLFT10GEN- 10884521516328, DLVLFT10GEN - 10884521787056 , VLFT10GENZD - 10884521640474/Software: v4.0.1, v4.0.2 and v4.0.3. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Due to software issue, New systems may exhibit an error which may prohibit use of new systems resulting in system being inoperable

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Covidien
Distributor
Worldwide distribution - US: Nationwide and surrounding territories.
Lot
Ref-UDI: VLFT10GEN- 10884521516328, DLVLFT10GEN - 10884521787056 , VLFT10GENZD - 10884521640474/Software: v4.0.1, v4.0.2 and v4.0.3
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Covidien Valleylab FT10, FT Series Energy Platform, REF: VLFT10GEN, DLVLFT10GEN, VLFT10GENZD recalled?

Yes. FDA published recall Z-0631-2024 on January 10, 2024. Reported hazard: Due to software issue, New systems may exhibit an error which may prohibit use of new systems resulting in system being inoperable

What should I do if I have this product?

Voluntary: Firm initiated · Letter